CVS Health Corp ( (CVS) ) has released its Q3 earnings. Here is a breakdown of the information CVS Health Corp presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
CVS Health Corporation, a leading health solutions company, operates in the healthcare sector with a focus on retail pharmacy, medical clinics, and pharmacy benefits management. In its third quarter of 2025, CVS Health reported record revenues of $102.9 billion, a 7.8% increase from the previous year, despite a GAAP diluted loss per share of $3.13 due to a $5.7 billion goodwill impairment charge. Adjusted earnings per share rose to $1.60, reflecting improved performance in the Health Care Benefits segment. Key highlights include Aetna’s high Medicare Advantage Star Ratings and a successful vaccination campaign. The company updated its full-year guidance, adjusting its GAAP earnings outlook to a loss but raising its adjusted EPS forecast. Looking ahead, CVS Health remains focused on enhancing operational efficiency and financial performance, with a commitment to providing integrated healthcare solutions.